Dantrolene reconstitution delays during suspected MH: practical solutions?

During a laparoscopic cholecystectomy under sevoflurane + succinylcholine anesthesia, a 35F developed unexplained tachycardia (HR 130), rising ETCO2 (from 38 to 62 mmHg over 15 minutes), and jaw rigidity post-intubation. Temperature is rising (37.8 to 38.5°C in 20 minutes).

Suspected malignant hyperthermia. We stopped sevoflurane, switched to TIVA (propofol/remifentanil), hyperventilated with 100% O2. Surgeon is closing.

The practical problem: Dantrolene reconstitution takes 2 to 3 minutes per vial (20mg/vial), and a 70kg patient needs approximately 175mg (2.5 mg/kg). That is 9 vials. With one person reconstituting, this takes 20+ minutes.

Questions:

How does your OR stock dantrolene? How many vials are immediately available?
Is Ryanodex (concentrated dantrolene) available at your center?
What is your parallel management algorithm while waiting for dantrolene?
Post-crisis: what monitoring and for how long?

Sharing our institutional protocol after this event prompted a departmental review:

1. Stocking: We now keep 36 vials (720mg) of classic dantrolene in every OR complex, plus an MH cart with all ancillary supplies (cold saline, bicarbonate, insulin, calcium chloride, ABG syringes). Previously we had 18 vials, which is insufficient for a large patient or refractory case.

2. Ryanodex: Not yet available at our center, but we are procuring it. Ryanodex contains 250mg per vial and reconstitutes in under 60 seconds with only 5mL of sterile water. For a 70kg patient, one vial provides the full initial dose. This eliminates the reconstitution delay entirely.

3. Parallel management while waiting for dantrolene:

Switch to TIVA immediately (already done)
Hyperventilate with 100% O2 at high fresh gas flows (>10 L/min)
Active cooling: cold IV saline 30 mL/kg, ice packs to axillae and groin, lavage if available
Treat hyperkalemia aggressively: calcium chloride 10mg/kg, insulin 10u + dextrose 50mL, bicarbonate 1 to 2 mEq/kg
Serial ABGs q15min
Foley catheter (watch for myoglobinuria, target UOP > 2 mL/kg/hr)
Call for help. Assign 2 to 3 people to reconstitute dantrolene simultaneously.

4. Post-crisis monitoring: ICU admission for minimum 24 hours. Serial CPK, potassium, myoglobin, coagulation studies (risk of DIC). Temperature and ETCO2 monitoring continuously. MH can recrudesce in 25% of cases, usually within 12 hours.

From the ICU receiving end, I want to add our checklist for post-MH patients:

Arterial line and central line if not already placed
CPK trending q6h until peak identified and declining (typical peak at 12 to 24 hours)
Serum myoglobin and urine myoglobin to assess rhabdomyolysis severity
Alkalinize urine with bicarbonate drip if myoglobinuria present (target urine pH > 6.5)
Dantrolene 1 mg/kg IV q4 to 6h for 24 to 48 hours post-crisis (maintenance dosing)
Watch for DIC: PT, aPTT, fibrinogen, D-dimer at admission and q12h
Genetic counseling referral and RYR1 mutation testing before discharge
Register the event with the MH hotline (MHAUS in the US, equivalent in India)

One overlooked point: family members need to be informed. MH susceptibility is autosomal dominant. First-degree relatives should be tested and should carry medical alert identification.

2 Answers